• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, April 2, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Health

UM researchers receive $700,000 in NIH funding to study tick-borne lyme disease

Bioengineer by Bioengineer
July 11, 2018
in Health
Reading Time: 2 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram
IMAGE

Credit: Micrograph by Dan Drecktrah.

MISSOULA – University of Montana researchers Dan Drecktrah and Scott Samuels were recently awarded $449,998 from the National Institutes of Health for the first year of a five-year project to study the bacterium that causes Lyme disease.

They will work in conjunction with Meghan Lybecker of the University of Colorado – Colorado Springs. Lybecker earned her Ph.D. from UM in 2007.

Together they will investigate the "Regulation of glycerol utilization in Borrelia burgdorferi." With an estimated 300,000 cases annually, Lyme disease is the most prevalent vector-borne illness in the United States. It results from infection with the spirochete Borrelia burgdorferi transmitted via the bite of a tick.

The objective of their work is to understand the regulatory mechanisms that allow B. burgdorferi to respond and adapt to varied carbon sources in tick-to-mammal transmission and in Lyme disease pathogenesis, which will lead to improved diagnostic, prevention and treatment strategies. The long-term objective is to alleviate the human disease.

Drecktrah also recently received nearly $260,000 in NIH funding for his project titled "Metabolic regulation during the two-host lifecycle of Borrelia." In this project, he will investigate a novel signaling pathway that regulates the interaction of B. burgdorferi with its tick vector. The long-term objective of this project is to understand the unique strategies and mechanisms B. burgdorferi uses to persist in the tick and transmit to mammals.

###

Media Contact

Sara Jestrab
[email protected]
406-243-6003

http://www.umt.edu

Original Source

http://news.umt.edu/2018/07/071018tick.php

Share12Tweet8Share2ShareShareShare2

Related Posts

Flu Vaccine May Shield Against Heart Attack and Stroke, Even in Those Who Contract the Virus

April 2, 2026

First-in-Class Dual HIF Inhibitors Eradicate Breast, Colorectal, Melanoma, and Prostate Tumors in Mice Combined with Immunotherapy

April 2, 2026

Blocking RUNX1/2 Boosts Fat Tissue Thermogenesis

April 2, 2026

Cysteine Sulfenylation of p-GSK-3β Drives Liver Insulin Resistance

April 2, 2026
Please login to join discussion

POPULAR NEWS

  • blank

    Revolutionary AI Model Enhances Precision in Detecting Food Contamination

    96 shares
    Share 38 Tweet 24
  • Imagine a Social Media Feed That Challenges Your Views Instead of Reinforcing Them

    1007 shares
    Share 398 Tweet 249
  • Promising Outcomes from First Clinical Trials of Gene Regulation in Epilepsy

    51 shares
    Share 20 Tweet 13
  • Popular Anti-Aging Compound Linked to Damage in Corpus Callosum, Study Finds

    44 shares
    Share 18 Tweet 11

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Flu Vaccine May Shield Against Heart Attack and Stroke, Even in Those Who Contract the Virus

Breakthrough in Room-Temperature Drying Provides Affordable Method to Stabilize Functional Proteins

First-in-Class Dual HIF Inhibitors Eradicate Breast, Colorectal, Melanoma, and Prostate Tumors in Mice Combined with Immunotherapy

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 78 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.